InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-4.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by LANE ANDREW H, Vice-Président Exécutif. Director active across 1 company, notably Abbott Laboratories. Cumulatively, 4 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €2.3m. Activity tracked since 27 August 2021. The latest transaction was filed on 15 November 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
10,000 shares@ US$130.00910.2% of flowCommon shares without par valueSEC:0001415889-21-005272
10,000 shares@ US$130.0090.0005% mcap10.2% of flowCommon shares without par valueSEC:0001415889-21-005272:0
135,925 shares@ US$38.400.0020% mcap39.8% of flowCommon shares without par valueSEC:0001415889-21-004154:0
135,925 shares@ US$38.4039.8% of flowCommon shares without par valueSEC:0001415889-21-004154
4 of 4 declarations
About LANE ANDREW H
Lane Andrew H is the Executive Vice President at Abbott Laboratories. He is responsible for managing operations and the company's strategy. His role is crucial in ensuring efficiency and growth for Abbott in the global market.
